THE ROLE OF XENOBIOTIC ENZYME GENES OF THE FIRST AND SECOND PHASES IN THE PATHOGENESIS OF FETAL GROWTH RESTRICTION SYNDROME

Authors

  • N.N. Mavlyanova Republican Specialized Scientific and Practical Medical Center of Obstetrics and Gynecology, Research Institute of Hematology and Blood Transfusion
  • D.K. Najmutdinova Republican Specialized Scientific and Practical Medical Center of Obstetrics and Gynecology, Research Institute of Hematology and Blood Transfusion
  • K.T. Boboev Republican Specialized Scientific and Practical Medical Center of Obstetrics and Gynecology, Research Institute of Hematology and Blood Transfusion

Abstract

biotransformation enzyme of xenobiotics in fetal development restriction syndrome
evaluation of allelic variants of ri genes. Materials and Methods: Fetal Development Limitation
DNA samples from pregnant women and donor healthy, expressed in dromi, glutathione
genes GERTM1 (1p13.3), GSTT1 (22q11.2) and glutathione transferase GSTP1 (IIe 105 Val). In all pregnant women
general-clinical, laboratory and functional, molecular-genetic research was carried out. Results:
studies have shown that the development of fetal developmental restriction syndrome

Downloads

Published

2020-07-08

How to Cite

Mavlyanova, N., Najmutdinova, D., & Boboev, K. (2020). THE ROLE OF XENOBIOTIC ENZYME GENES OF THE FIRST AND SECOND PHASES IN THE PATHOGENESIS OF FETAL GROWTH RESTRICTION SYNDROME. Toshkent Tibbiyot Akademiyasi Axborotnomasi, (1), 121-127. Retrieved from https://journals.tma.uz/index.php/ttaa/article/view/29

Issue

No. 1 (2020): TTAA

Section

Clinical Medicine